Cargando…
Adjuvant therapy for renal cell carcinoma, finally a new standard?
Localized renal cell carcinoma (RCC) has the potential to be cured with surgery alone; however, some patients have a high risk of relapse and may benefit from additional treatment. Several efforts have been made to identify effective strategies, with mostly negative results. However, recent results...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Frontiers Media S.A.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9557147/ https://www.ncbi.nlm.nih.gov/pubmed/36249058 http://dx.doi.org/10.3389/fonc.2022.926661 |